home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences

Search

 
  PHARMA & BIOTECH LICENSING & DEAL-MAKING SUMMIT  
  May 14, 2001

Biotechnology

 
     
  Strategic Research Institute, The Rittenhouse Hotel, Philadelphia, PA
June 4-5, 2001



-Deals
-Structure
-Valuation
-Compensation
-Hot Enabling Technologies
-Key Therapeutic Classes
Deals!
-The Human Genome Sciences - Cambridge Antibody Technologies Collaboration
-The Genzyme Molecular Oncology - Pudue Pharma Alliance in Immunotherapy
-The CuraGen and Bayer AG Alliance - Landmark Drug Discovery, Development and Pharmacogenomic Partnership
-Taarget Family Deal Making: The Vertex - Novartis Collaboration
-Spreading Risk Across Early-Stage Collaborations Through Structured Financing Arrangements - Elan Corporation
-The story of a Development and Commercialization Agreement: The Bristol-Myers Squibb - Otsuka Partnership


 
 
Organized by: Strategic Research Institute
Invited Speakers: THE FOLLOWING ARE CONFIRMED TO SPEAK:
CHEIL JEDANG PHARMACEUTICALS, METHA PARTNERS LLC, HUMAN GENOME SCIENCES, INC., ELAN CORPORATION, HOFFMAN-LA ROCHE, ALKERMES, INC., LORUSSO & LOUD, GENZYME MOLECULAR ONCOLOGY, ELI LILLY & COMPANY, LEGG MASON WOOD WALKER, CURAGEN CORPORATION, VERTEX PHARMACEUTICALS, BRISTOL-MYERS SQUIBB, LION BIOSCIENCES, INC., NIH OFFICE OF TECHNOLOGY TRANSFER, BROOKHAVEN NATIONAL LABORATORY.
 
Deadline for Abstracts: all have been submitted
 
Registration: To Register Call 1-888-666-8514
E-mail: science@srinstitute.com
 
  Posted by:   edrilon  
Host: 12.3.58.10
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2001 HUM-MOLGEN. All rights reserved. Liability and Copyright.